Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of RNA01:23

Types of RNA

73.7K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
73.7K
Types of RNA01:20

Types of RNA

11.9K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
11.9K
Experimental RNAi02:15

Experimental RNAi

8.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small molecule inhibition of CPSF3 may impact R-loop distribution and abundance.

Bioorganic & medicinal chemistry letters·2026
Same author

Applying Synthetic Nucleic Acid Therapeutics to Gene Activation for Haploinsufficient Diseases.

Nucleic acid therapeutics·2025
Same author

Nuclear Argonaute:miRNA complexes recognize target sequences within chromatin-associated RNA and silence gene expression.

Nucleic acids research·2025
Same author

g.nome, A Transparent Bioinformatics Pipeline that Enables Differential Expression and Alternative Splicing Analysis by Non-Computational Biologists.

bioRxiv : the preprint server for biology·2025
Same author

Small molecule inhibition of CPSF3 impacts R-loop distribution and abundance.

bioRxiv : the preprint server for biology·2025
Same author

Nuclear Argonaute:miRNA complexes recognize target sequences within chromatin and silence gene expression.

bioRxiv : the preprint server for biology·2025
Same journal

R&D productivity trends for biopharma companies in Asia and emerging markets.

Nature reviews. Drug discovery·2026
Same journal

Growth in clinical research capability in China and impact on the pharmaceutical sector.

Nature reviews. Drug discovery·2026
Same journal

Circular RNA guides exon skipping in DMD.

Nature reviews. Drug discovery·2026
Same journal

p38α inhibition restores axonal transport.

Nature reviews. Drug discovery·2026
Same journal

Inflammatory bowel disease-on-a-chip.

Nature reviews. Drug discovery·2026
Same journal

Designing GPCR-targeted miniproteins.

Nature reviews. Drug discovery·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K

Non-coding RNAs as drug targets.

Masayuki Matsui1, David R Corey1

  • 1Departments of Pharmacology and Biochemistry, UT Southwestern, Dallas, Texas 75390-9041, USA.

Nature Reviews. Drug Discovery
|July 23, 2016
PubMed
Summary
This summary is machine-generated.

Non-coding RNAs (ncRNAs) play crucial roles in gene expression and disease. Targeting these molecules offers novel therapeutic opportunities, leveraging existing mRNA-targeting technologies to overcome challenges in drug development.

More Related Videos

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

26.4K
Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture
10:34

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture

Published on: July 22, 2016

24.5K

Related Experiment Videos

Last Updated: Mar 17, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K
RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

26.4K
Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture
10:34

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture

Published on: July 22, 2016

24.5K

Area of Science:

  • Genomics and Molecular Biology
  • RNA Biology
  • Drug Discovery and Development

Background:

  • The majority of the human genome produces non-coding RNAs (ncRNAs), which are critical regulators of gene expression.
  • Dysregulation of ncRNAs is implicated in various disease pathologies.
  • ncRNAs represent a promising new class of therapeutic targets.

Purpose of the Study:

  • To review the diverse landscape of ncRNAs, including microRNA, intronic RNA, repetitive RNA, and long non-coding RNA.
  • To assess the therapeutic potential of targeting ncRNAs for disease treatment.
  • To identify and discuss the challenges associated with developing ncRNA-based therapeutics.

Main Methods:

  • Literature review and synthesis of current research on ncRNA biology and therapeutic strategies.
  • Analysis of existing technologies for targeting messenger RNA (mRNA) and their applicability to ncRNAs.
  • Discussion of the unique challenges and potential solutions in ncRNA drug development.

Main Results:

  • ncRNAs encompass a wide range of molecules with significant roles in cellular processes and disease.
  • Therapeutic targeting of ncRNAs presents novel opportunities but also unique technical and mechanistic challenges.
  • Lessons learned from mRNA-targeting technologies may inform ncRNA therapeutic development.

Conclusions:

  • ncRNAs are emerging as critical players in health and disease, offering new avenues for drug discovery.
  • Overcoming the challenges in ncRNA targeting will require innovative approaches, potentially building upon mRNA-targeting strategies.
  • Further research into the biology and therapeutic exploitation of ncRNAs is warranted.